Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyeloctic leukemic cells via cyclic AMP-independent mechanism

Life Sciences

Volumn 63, Issue 4, 1998, Pages 265-274

  Zhu, Wen Hui ^a,b   Majluf Cruz, Abraham ^a   Omburo, George A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Cyclic AMP; HL60 cell line; Phosphodiesterases

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 8 BROMO CYCLIC AMP; 8 BROMO CYCLIC GMP; BUCLADESINE; CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; CYCLIC GMP; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; MILRINONE; PACLITAXEL; PHOSPHODIESTERASE; ROLIPRAM; THAPSIGARGIN; TREQUINSIN; ZAPRINAST;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL STRAIN HL 60; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL; PROTEIN EXPRESSION; SECOND MESSENGER;

1-METHYL-3-ISOBUTYLXANTHINE; 3',5'-CYCLIC-GMP PHOSPHODIESTERASE; 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; 4-(3-BUTOXY-4-METHOXYBENZYL)-2-IMIDAZOLIDINONE; APOPTOSIS; CYCLIC AMP; CYCLIC GMP; FEMALE; HL-60 CELLS; HUMANS; MILRINONE; PHOSPHODIESTERASE INHIBITORS; PYRIDONES; PYRROLIDINONES; ROLIPRAM;

EID: 0032546883     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00270-7     Document Type: Article

References (23)

1. 1. E. LALLI, P. SASSONE-CORSI, and R. CEREDIG, EMBO J. 15 528-537 (1996).
2. 2. D. J. MCCONKEY, S. ORRENIUS, S. OKRET, and M. JONDAL, FASEB J. 7 580-585 (1993).
3. 3. D. J. MCCONKEY, S. ORRENIUS, and M. JONDAL, J. Immunol. 145 1227-1230 (1990).
4. 4. P. SUTTON, J. BEAVER, and P. WARING, Biochem. Pharmacol. 50 2009-2014 (1995).
5. 5. J. KIEFER, S. OKRET, M. JONDAL, and D. J. MCCONKEY, J. Immunol. 155 4525-4528 (1995).
6. 6. D. AHARONI, A. DANTES, M. OREN, and A. AMSTERDAM, Exp. Cell. Res. 218 271-282 (1995).
7. 7. A. G. ROSSI, J. M. COUSIN, I. DRASFIELD, M. F. LAWSON, E. R. CHILVERS, and C. HASLETT, Biochem. Biophys. Res. Commun. 217 892-899 (1995).
8. 8. M. V. BERRDGE, A. S. TAN, and C. J. HILTON, Exp. Hematol. 21 269-276 (1993).
9. 9. T. ARAI, K. HIROMATSU, N. KOBAYASHI, M. TAKANO, H. ISHIDA, Y. NIMURA, and Y. YOSHIKAI, J. Immunol. 155 5743-5749 (1995).
10. 10. S. R. D'MELLO, C. GALLI, T. CIOTTI, and P. CALISSANO, Proc. Natl. Acad. Sci. USA. 90 10989-10993 (1993).
11. 11. J. A. BEAVO, M. CONTI, and R. J. HEASLIP, Mol. Pharmacol. 46 399-405 (1994).
12. 12. S. A. HARRISON, D. H. REIFSNYDER, B. GALLIS, G. G. CADD, and J. A. BEAVO, Mol. Pharmacol. 29 506-514 (1986).
13. 13. D. RUPERT, and K.U. WEITHMANN, Life Sci. 31 2037-2043 (1982).
14. 14. M. L. REEVES, B. K. LEIGH, and P. J. ENGLAND, Biochem. J. 241 535-539 (1987).
15. 15. Y. KATANO, and M. ENDOH, Biochem. Biophys. Res. Commun. 167 123-129 (1990).
16. 16. G. P. LIVI, P. KMETZ, M. M. MCHALE, L. B. CIESLINSKI, G. M. SATHE, D. P. TAYLOR, R. L. DAVIS, T. J. TORPHY, and J. M. BALCAREK, Mol. Cell Biol. 10 2678-2686 (1990).
17. 17. W. H. ZHU, and T. T. LOH, Life Sci. 57 2091-2099 (1995).
18. 18. J. A. BEAVO, Second Messenger Phosphoprotein Res. 22 1-37 (1988).
19. 19. S. B. SHETH, and R. W. COLMAN, Seminars in Hematology 32 110-119 (1995).
20. 20. B. T. GJERTSEN, G. MELLGREN, A. OTTEN, E. MARONDE, H. G. GENIESER, B. JASTORFF, O. K. VINTERMYR, G. S. MCKNIGHT, and S. O. DØSKELAND, J. Biol. Chem. 271 18-26 (1996).
21. 21. F. MENTZ, M. D. MOSSALAYI, F. OUAAZ, S. BAUDET, F. ISSALY, S. KTORZA, M. SEMICHON, J. L. BINET, and H. MERLE-BERAL, Blood 88 2172-2182 (1996).
22. 22. X. JIANG, J. LI, M. PASKIND, and P. M. EPSTEIN, Pro. Natl. Acad. Sci. USA. 93 11236-11241 (1996).
23. 23. T. MÜLLER, P. ENGELS, and J. R. FOZARD, TiPS 17 294-298 (1997).